5AM Venture Management, LLC
Top Portfolio Positions
20 positions ·
$360,212,474 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ERAS |
Erasca, Inc.
Healthcare
|
3,485,971 | $56,403,010 | 15.66% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
4,056,379 | $51,191,502 | 14.21% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
1,029,298 | $39,422,113 | 10.94% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
5,869,091 | $25,882,691 | 7.19% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
580,945 | $23,075,135 | 6.41% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
797,600 | $22,532,200 | 6.26% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
950,011 | $19,313,723 | 5.36% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
606,660 | $18,751,860 | 5.21% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
497,270 | $15,773,404 | 4.38% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
2,353,304 | $15,155,277 | 4.21% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CNTA
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,075,135 | 580,945 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,529,434 | 580,945 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,512,916 | 680,945 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,918,617 | 830,945 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,948,989 | 830,945 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,918,328 | 830,945 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,547,150 | 1,285,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,242,350 | 1,245,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,068,500 | 1,245,000 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||